Active Ingredient(s):Brimonidine Tartrate + Timolol Maleate FDA Approved: * October 30, 2007 Pharm Company: *ALLERGAN Category:Vision / Eye Health
Brimonidine/timolol, sold under the brand name Combigan, is a fixed-dose combination medication eye drop indicated for the treatment of glaucoma. It is a combination of brimonidine (an α2 adrenergic agonist) and timolol (a β adrenergic blocker), in concentrations of 0.2% and 0.5% respectively. Both substances work by decreasing the synthesis of aqueous humor.
Combigan is marketed and sold by Allergan. It has been approved by regulatory authorities in Europe, Canada, and the United S...
* May have multiple approval dates, manufacturers, or labelers. 2 Discussions